New Hodgkin's Lymphoma Treatment Boosts Fertility Preservation Without Sacrificing Survival

A new study reveals that the BrECADD chemotherapy regimen for Hodgkin's lymphoma preserves fertility far better than standard treatments—without reducing survival rates. Learn how this breakthrough is changing cancer care.